PortfoliosLab logoPortfoliosLab logo
UYM vs. CURE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

UYM vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra Basic Materials (UYM) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UYM achieves a 27.95% return, which is significantly higher than CURE's -7.96% return. Over the past 10 years, UYM has underperformed CURE with an annualized return of 12.48%, while CURE has yielded a comparatively higher 13.49% annualized return.


UYM

1D
3.74%
1M
1.10%
YTD
27.95%
6M
30.38%
1Y
36.06%
3Y*
11.85%
5Y*
4.60%
10Y*
12.48%

CURE

1D
-0.55%
1M
13.71%
YTD
-7.96%
6M
-6.00%
1Y
28.51%
3Y*
3.05%
5Y*
1.51%
10Y*
13.49%
*Multi-year figures are annualized to reflect compound growth (CAGR)

UYM vs. CURE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UYM
ProShares Ultra Basic Materials
27.95%9.46%-8.00%17.47%-23.10%54.58%16.56%35.09%-35.68%51.51%
CURE
Direxion Daily Healthcare Bull 3x Shares
-7.96%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%

Correlation

The correlation between UYM and CURE is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.44

Correlation (3Y)
Calculated over the trailing 3-year period

0.50

Correlation (5Y)
Calculated over the trailing 5-year period

0.53

Correlation (10Y)
Calculated over the trailing 10-year period

0.54

Correlation (All Time)
Calculated using the full available price history since Jun 15, 2011

0.56

The correlation between UYM and CURE shifts across timeframes, from 0.44 (1 year) to 0.56 (all time), reflecting how their relationship changes across market environments.

UYM vs. CURE - Sectors Allocation Comparison


Sectors
UYM
CURE

Basic Materials

87.6%

-

Consumer Cyclical

12.4%

-

Industrials

1.1%

-

Communication Services

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Healthcare

-

100.0%

Real Estate

-

-

Technology

-

-

Utilities

-

-

Basic Materials

UYM
87.6%
CURE

-

Consumer Cyclical

UYM
12.4%
CURE

-

Industrials

UYM
1.1%
CURE

-

Communication Services

UYM

-

CURE

-

Consumer Defensive

UYM

-

CURE

-

Energy

UYM

-

CURE

-

Financial Services

UYM

-

CURE

-

Healthcare

UYM

-

CURE
100.0%

Real Estate

UYM

-

CURE

-

Technology

UYM

-

CURE

-

Utilities

UYM

-

CURE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UYM vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UYM
UYM Risk / Return Rank: 2929
Overall Rank
UYM Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
UYM Sortino Ratio Rank: 3030
Sortino Ratio Rank
UYM Omega Ratio Rank: 2828
Omega Ratio Rank
UYM Calmar Ratio Rank: 3131
Calmar Ratio Rank
UYM Martin Ratio Rank: 2929
Martin Ratio Rank

CURE
CURE Risk / Return Rank: 2121
Overall Rank
CURE Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 2424
Sortino Ratio Rank
CURE Omega Ratio Rank: 2222
Omega Ratio Rank
CURE Calmar Ratio Rank: 2222
Calmar Ratio Rank
CURE Martin Ratio Rank: 1919
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UYM vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Basic Materials (UYM) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


UYMCUREDifference
Sharpe ratioReturn per unit of total volatility

+0.34

Sortino ratioReturn per unit of downside risk

+0.28

Omega ratioGain probability vs. loss probability

1.17

1.13

+0.04

Calmar ratioReturn relative to maximum drawdown

1.38

0.85

+0.52

Martin ratioReturn relative to average drawdown

3.67

1.94

+1.73

UYM vs. CURE - Sharpe Ratio Comparison

The current UYM Sharpe Ratio is 0.94, which is higher than the CURE Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of UYM and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

UYM vs. CURE - Drawdown Comparison

The maximum UYM drawdown since its inception was -92.77%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for UYM and CURE.


Loading charts...

Drawdown Indicators


UYMCUREDifference

Max Drawdown

Largest peak-to-trough decline

-92.77%

-69.19%

-23.58%

Max Drawdown (1Y)

Largest decline over 1 year

-23.85%

-31.10%

+7.25%

Max Drawdown (3Y)

Largest decline over 3 years

-43.88%

-51.93%

+8.05%

Max Drawdown (5Y)

Largest decline over 5 years

-48.25%

-52.23%

+3.98%

Max Drawdown (10Y)

Largest decline over 10 years

-73.31%

-69.19%

-4.12%

Current Drawdown

Current decline from peak

-7.32%

-26.94%

+19.62%

Average Drawdown

Average peak-to-trough decline

-42.06%

-18.16%

-23.90%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.95%

13.71%

-4.76%

Volatility

UYM vs. CURE - Volatility Comparison

ProShares Ultra Basic Materials (UYM) and Direxion Daily Healthcare Bull 3x Shares (CURE) have volatilities of 14.01% and 14.30%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UYMCUREDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.01%

14.30%

-0.29%

Volatility (6M)

Calculated over the trailing 6-month period

27.29%

30.87%

-3.58%

Volatility (1Y)

Calculated over the trailing 1-year period

35.09%

44.32%

-9.23%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.49%

43.84%

-4.35%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

42.86%

49.59%

-6.73%

UYM vs. CURE - Expense Ratio Comparison

UYM has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.


Dividends

UYM vs. CURE - Dividend Comparison

UYM's dividend yield for the trailing twelve months is around 1.19%, more than CURE's 1.16% yield.


PositionTTM20252024202320222021202020192018201720162015
CURE
Direxion Daily Healthcare Bull 3x Shares
1.16%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%0.00%
UYM
ProShares Ultra Basic Materials
1.19%1.47%0.98%0.28%0.88%0.52%0.56%1.24%0.94%0.38%0.55%0.42%

Frequently Asked Questions


UYM and CURE have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CURE has higher volatility (14.30%) compared to UYM (14.01%). In terms of maximum drawdown, UYM dropped -92.77% vs CURE's -69.19%.

On 10-year performance, CURE leads with 13.49% vs 12.48% for UYM. On fees, UYM is cheaper at 0.95% per year. On volatility, UYM has been the lower-risk option at 14.01%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, CURE has performed better with a 13.49% return vs 12.48%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

UYM is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.

UYM has the higher dividend yield at 1.19%, compared with 1.16% for CURE.

UYM tracks Dow Jones U.S. Basic Materials Index (200%), while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for UYM and 1.08% for CURE.

UYM currently has the higher Sharpe Ratio (0.94 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UYM and CURE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer